CardioComm Solutions Inc (CVE:EKG) Completes Equity Financing


CardioComm Solutions Inc (CVE:EKG) has closed its previously reported equity financing for total gross proceeds of $76,000. This deal was planned to permit parties who failed to participate in the firm’s December 2016 private placement to capitalize in the firm. The financing proceeds will be used for regulatory submissions, working capital and general operations.

The update

Under the financing, CardioComm released 1.52 million units priced $0.05 per unit. Each of this unit is comprised of one purchase warrant and a common share. Warrant can be exercised for an additional equity at $0.075 for 2-years. The securities released under the financing are conditional to a 4-month hold period.

Etienne Grima, the CEO of CardioComm, has privately sold 1.1 million shares and has utilized the revenue from the sales to buy 1.1 million units under the financing. The unit issuance to Mr. Grima is stated to be a related party transaction. The firm plans to rely on exemptions from the official valuation and minority shareholder nod requirements offered under sections 5.7(a) and 5.5(a) of Multilateral Instrument 61-101 on the base that the value of the issued units to Mr. Grima does not surpass 25% of the fair market value of the firm’s market capitalization.

CardioComm proprietary and patented technology is used in items for recording, viewing, storing and analyzing electrocardiograms for management and diagnosis of cardiac patients. Offerings are sold globally via combination of an external supply network and a North American-based strong sales team.

The firm has earned the ‘ISO 13485’ certification, is HIPAA compliant, HPB approved and has obtained FDA market nod for its software devices. It is headquartered in Toronto, Canada.

In the last trading session, the stock price of CardioComm declined over 5% to close the day at $0.0800. After the recent decline, the market cap of firm stands at $9.98 million.

This report is for information purposes only, and is neither a solicitation or recommendation to buy nor an offer to sell securities. Financials Trend is not-a-registered-investment-advisor. Financials Trend is not a broker-dealer. Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. Financials Trend accepts no liability for any losses arising from an investor's reliance on the use of this material. Financials Trend sometimes gets compensated up to one hundred and fifty thousand dollars per month for featuring particular stocks. See site disclaimer for complete compensation. Financials Trend and its affiliates or officers currently hold no shares of these stocks. Financials Trend and its affiliates or officers will purchase and sell shares of common stock of these stocks, in the open market at any time without notice. Financials Trend will not update its purchases and sales of these stocks in any future postings on Financials Trend's websites. Certain information included herein is forward-looking within the context of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. The words "may", "would," "will," "expect," "estimate," "anticipate," "believe," "intend," " project," and similar expressions and variations thereof are intended to identify for ward-looking statements. Such forward- looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. *Financials Trend does not set price targets on securities. Never invest into a stock discussed on this web site or in this email alert unless you can afford to lose your entire investment.